Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2005
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005CA2543533A1 2-cyanopyrrolidinecarboxamide compound
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005CA2543346A1 Benzimidazolyl derivatives
05/12/2005CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005CA2487210A1 Asymmetrical linear organic oligomers
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529046A1 Substituted benzimidazole compounds
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1528924A1 Mch1r antagonists
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
05/10/2005US6890930 Quinazolinones
05/10/2005US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005US6890885 Herbicidal composition
05/06/2005WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
05/06/2005WO2005040155A1 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists
05/06/2005WO2005040151A1 Pyrazine derivatives and pharmaceutical use thereof
05/06/2005WO2005040137A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors
05/06/2005WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function
05/06/2005WO2005040135A1 Antistress drug and medical use thereof
05/06/2005WO2005040128A1 Heterocyclyl compounds
05/06/2005WO2005040126A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
05/06/2005WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer
05/06/2005WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
05/06/2005WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto
05/06/2005WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors
05/06/2005WO2005028443A3 Protein tyrosine kinase enzyme inhibitors
05/06/2005WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005CA2543644A1 Pyrazine derivatives and pharmaceutical use thereof
05/06/2005CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer
05/06/2005CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
05/05/2005US20050096468 Inhibitors of histone deacetylase
05/05/2005US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation
05/05/2005US20050096363 Activator of peroxisome proliferator-activated receptor delta
05/05/2005US20050096354 Process for the preparation of substituted aryl pyrazoles
05/05/2005US20050096350 Halo substituted benzo[b]thiophenes as therapeutic agents
05/05/2005US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile
05/05/2005US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents
05/05/2005US20050096330 N-(indolecarbonyl) piperazine derivatives
05/05/2005US20050096316 Quinoline derivatives(2)
05/05/2005US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders
05/04/2005EP1528055A2 Sulphonamide Derivatives
05/04/2005EP1527069A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
05/04/2005EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors
05/04/2005EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors
05/04/2005EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
05/04/2005EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents
05/04/2005EP1411881B1 5ht2c receptor modulators
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1199956C Oxadiazole derivs. having anticancer effects
05/04/2005CN1199954C Benzodiazepine derivatives
05/04/2005CN1199947C Process for production of pyridine derive
05/03/2005US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
05/03/2005US6887877 Viricide for hepatitis virus
05/03/2005US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia
05/03/2005US6887865 N-heterocyclic derivatives as NOS inhibitors
05/03/2005US6887831 For use as herbicides
05/03/2005CA2320388C Novel dihydroxyhexanoic acid derivatives
05/03/2005CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides
04/2005
04/28/2005WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
04/28/2005WO2005037827A1 Process for preparing benzimidazole thiophenes
04/28/2005WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation
04/28/2005WO2005037792A1 Derivatives of n-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
04/28/2005WO2005037781A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
04/28/2005WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
04/28/2005WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
04/28/2005WO2005037271A2 Large conductance calcium-activated k channel opener
04/28/2005WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
04/28/2005WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators
04/28/2005WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
04/28/2005WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
04/28/2005WO2004065539A3 Androgen receptor antagonists
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/28/2005US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/28/2005US20050090543 Method for the preparation of tetrahydrobenzothiepines
04/28/2005US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer
04/28/2005US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent
04/28/2005US20050090524 Novel adamantane derivatives
04/28/2005US20050090503 5-HT receptor ligands and uses thereof
04/28/2005US20050090501 Heteroaryl-cyclic acetals
04/28/2005US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative
04/28/2005US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders